Latest drug development News

Australian researchers use a quantum computer to simulate how real molecules behave
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
Melbourne scientists identify potential new target for neurodegenerative diseases
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling…
New Cystic Fibrosis Research Centre Sets Up In Melbourne
Cancer research in the US is world class because of its broad base of funding − with the government pulling out, its…
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
A Colloidal Crystal Model for Controlled Polymorph Selection
Scientists develop new method to measure and predict hydrogen bond strength in confined water
Drug breakthrough sparks hope for families affected by MND gene SOD1
Lab-grown meat: you may find it icky, but it could drive forward medical research
Regulatory DNA Links Cancer And Tissue Regeneration
nib funds local research to tackle chronic disease, mental health and knee replacements
Percheron updates shareholders after disappointing clinical trial result
3D Kidney Diagnostics Using Advanced Light Microscopy
Why are suicide rates so high in bipolar disorder, and what can we do about it?
Crown Bioscience Appoints John Gu as Chief Executive Officer
‘Pac-Man with a ponytail’ proteins regulate everything from night vision to heartbeats – studying what GRKs look like could improve an array of drugs
Bacterial ‘jumping genes’ can target and control chromosome ends
UQ Biotech Innovation Partnership Forges Second Startup
New understanding of cancer drugs can improve treatments
New understanding of cancer drugs may improve treatments
New approach for studying drug-proteoform interactions can improve cancer treatments
Using Ancient Knowledge To Combat IBD
Neuren receives rare paediatric disease designation from the US FDA
p53 is both your genome’s guardian and weakness against cancer – scientists are trying to repair or replace it when it goes awry
Syntara’s topical anti-fibrotic drug leads to significant normalisation of skin in established scars
Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit
Genetic Analysis CAPS Search For Cure
AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer
Cell Atlas Of Human Hypothalamus
Noxopharm says SOF-SKN passes required in vitro safety tests
Investing In Medtech So Patients Can Breathe Easier
The Knut and Alice Wallenberg Foundation supports life science research at KI
Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors
Will AI revolutionize drug development? Researchers explain why it depends on how it’s used
Race Oncology Appoints Opthea Founder To Its Board
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
AusBiotech Celebrates ESIF Winners
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
New open-source platform supports large imaging data analysis
Lars H. Lund, one of the researchers on the Highly Cited Researchers 2024 list
Lars Lund, one of the researchers on the Highly Cited Researchers 2024 list
Curtin Accelerate 2025 powers WA’s next wave of innovators
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
Race Oncology says it has discovered multiple novel FTO inhibitor candidates
Nearly 80 million SEK to OnkPat researchers from the Swedish Cancer Society